🟢 Oncolytics Biotech is trading 5.66% up in after-hours trading — cause unconfirmed

Oncolytics Biotech is trading at $0.50, up 5.66%, in after-hours trading; the cause of the rise remains unconfirmed.

• No confirmed company-specific announcement or late-breaking catalyst explaining the move was identified. An October 11 update reported accelerating enrollment in the REO 033 study, but available coverage does not connect it to the October 12 move.
• Broader indexes were mixed, and the available evidence does not establish a market-wide explanation.